Zoom imageVeterinarian Dr. Katja Beyer (right) and her assistant Andrea Kuapat (left) examining a dog.
The European Commission has approved two new companion animal products from Bayer, Veraflox™ and Procox™. Veraflox™ is the first next-generation veterinary fluoroquinolone antibiotic for the treatment of bacterial infection in cats and dogs. Procox™ is the first combination treatment for roundworm and coccidia in dogs.
“Bayer Animal Health is proud to introduce these two innovative treatments which will provide veterinarians with much needed, effective new treatment options for a range of indications,” said Jean-Luc Lowinski, Managing Director of Bayer Animal Health. “As an expert solution provider for animal health we have a strong and ongoing commitment to researching and developing innovative ways to address parasitic and bacterial infections in companion animals.”
The European Commission has approved Veraflox™ in 30 countries for the treatment of a range of infections caused by specific bacteria, and the product has already been launched in some countries.
Market introduction of Procox™ is scheduled for the second half of 2011.